You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
方达控股(01521.HK)中期经调整纯利增长138.6%至1210万美元
格隆汇 08-20 17:39

格隆汇8月20日丨方达控股(01521.HK)发布中期业绩,截至2019年6月30日止6个月,公司实现收入4968.9万美元,同比增长34.0%;毛利1924.9万美元,同比增长39.3%;公司股权持有人应占溢利929.4万美元,同比增长233.1%;经调整纯利约1210万美元,同比增长138.6%;基本每股收益0.006美元;不派中期股息。

公告表示,报告期内,集团收益增长主要由于集团进行的营销工作,使得其在美国及中国具有强劲的营销表现;及逐步增长的毒理学实验室服务。

集团作为一家快速增长的合同研究机构的持续进展,集团提供贯穿整个药物发现和开发过程中的一体化、科学驱动的研究、分析和开发服务,协助制药公司实现药物开发目标。集团在美国提供的服务包括在整个药物研发过程中的药物代谢和药代动力学、安全性和毒理学以及化学、制造和控制。集团于美国和中国提供贯穿整个药物研发过程中的生物分析服务。于中国,集团亦提供生物等效性及相关服务。集团亦向农药公司提供若干类型的服务。

报告期间,作为一家增值合作伙伴,集团专注于解决客户最重要及最复杂的药物发现及开发问题。在科学知识基础、专业技术知识以及在提供优质服务方面建立的良好声誉成为必备能力,让集团得以与关键客户建立长期战略关系及合作伙伴关系。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account